Novartis Ag NVS
NYSE NVS
$141.01 -0.05 (-0.04%)
At close: Oct 2, 2026 · 4:00 PM EDT

Novartis Ag (NVS) Return on Capital Employed [ROCE] (2009 - 2026)

Updated

Novartis Ag (NVS) posted Return on Capital Employed [ROCE] of 19.32% for Q2 2026, down 4.36 percentage points from 23.68% a year earlier and down 1.33 percentage points from the prior quarter.

Analysis

Novartis Ag (NVS) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends

For FY2025, Novartis Ag's Return on Capital Employed [ROCE] came in at 22.24%, up 2.16 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has increased for three consecutive years, with a five-year change of +10.97 percentage points (FY2020 to FY2025).
  • In prior years, Novartis Ag's Return on Capital Employed [ROCE] was 20.09% in FY2024 (+8.22 pp), 11.87% in FY2023 (+3.59 pp), 8.28% in FY2022 (-1.82 pp) and 10.10% in FY2021 (-1.18 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Capital Employed [ROCE] since Q3 2024.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in six of the last eight quarters, with an average year-over-year change of +3.29 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q4 2024, with a gain of 7.38 percentage points; the weakest was Q2 2026, with a drop of 4.36 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was 20.65% (Q1 2026), 21.56% (Q4 2025) and 23.78% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 17.83%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 17.92%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.54%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 16.66%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -5.97%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 11.86%
10 Vertex Pharmaceuticals 128.38 Bn 100.39 Bn 2.84 Bn 20.76%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.32%
Mar 31, 2026 20.65%
Dec 31, 2025 21.56%
Sep 30, 2025 23.78%
Jun 30, 2025 23.68%
Mar 31, 2025 22.79%
Dec 31, 2024 19.60%
Sep 30, 2024 18.78%
Jun 30, 2024 17.17%
Mar 31, 2024 15.51%
Dec 31, 2023 12.22%
Sep 30, 2023 14.09%
Jun 30, 2023 11.30%
Mar 31, 2023 10.00%
Dec 31, 2022 9.70%
Sep 30, 2022 10.23%
Jun 30, 2022 11.28%
Mar 31, 2022 12.29%
Dec 31, 2021 12.14%
Sep 30, 2021 12.69%
API Access

Novartis Ag Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=NVS&period=max&api_key=YOUR_API_KEY